Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R1GV
|
||||
Former ID |
DCL001180
|
||||
Drug Name |
DPX-Survivac
|
||||
Drug Type |
Vaccine
|
||||
Indication | Ovarian cancer [ICD9: 183; ICD10:C56] | Phase 1/2 | [551020] | ||
Company |
Immunovaccine
|
||||
Target and Pathway | |||||
Target(s) | Baculoviral IAP repeat-containing protein 5 | Target Info | [551020] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
Pathway Interaction Database | Aurora B signaling | ||||
Validated targets of C-MYC transcriptional activation | |||||
FOXM1 transcription factor network | |||||
Aurora A signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.